Bioventus Inc. (BVS)
undefined
undefined%
At close: undefined
9.60
-2.34%
After-hours Jan 06, 2025, 07:20 PM EST

Bioventus Inc. Revenue Breakdown

Quarter Sep 28, 2024Jun 29, 2024Mar 30, 2024
International Segment Revenue 16.05M 16.81M 15.18M
International Segment Revenue Growth -4.48% +10.75% n/a
U.S. Segment Revenue 122.91M 134.41M 114.28M
U.S. Segment Revenue Growth -8.56% +17.61% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021
Non-Us Revenue 62.48M 14.95M 43.34M
Non-Us Revenue Growth +317.93% -65.51% n/a
United States Revenue 449.86M 126.21M 387.55M
United States Revenue Growth +256.45% -67.43% n/a

Operating Expense Breakdown

Quarter Sep 28, 2024Jun 29, 2024Mar 30, 2024Dec 31, 2023Sep 30, 2023Jul 1, 2023Apr 1, 2023Dec 31, 2022Oct 1, 2022Jul 2, 2022Apr 2, 2022Dec 31, 2021Oct 2, 2021Jul 3, 2021Apr 3, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 28, 2019Jun 29, 2019Mar 29, 2019Mar 31, 2016Mar 31, 2015
Selling, General, and Administrative Revenue 81.09M 91.94M 77.84M 76.68M 69.82M 74.84M 80.86M 77.67M 78.95M 89.62M 86.12M 80.88M 69.64M 69.05M 34.69M 61.97M 50.30M 40.53M 40.28M 54.45M 45.12M 49.45M 49.45M 40.18M 37.27M
Selling, General, and Administrative Revenue Growth -11.80% +18.11% +1.51% +9.83% -6.71% -7.44% +4.11% -1.63% -11.90% +4.06% +6.48% +16.15% +0.85% +99.07% -44.03% +23.22% +24.08% +0.64% -26.04% +20.69% -8.76% n/a +23.06% +7.82% n/a
Research and Development Revenue 3.81M 3.99M 2.60M 3.26M 3.02M 3.40M 3.77M 6.81M 4.61M 6.37M 6.93M 7.10M 6.15M 4.84M 947.00K 2.89M 3.57M 2.60M 2.15M 3.14M 2.85M 2.53M 2.53M 3.72M 2.97M
Research and Development Revenue Growth -4.51% +53.56% -20.39% +8.19% -11.27% -9.89% -44.60% +47.53% -27.52% -8.11% -2.46% +15.44% +27.23% +410.67% -67.24% -19.00% +37.48% +20.97% -31.74% +10.35% +12.56% n/a -31.93% +25.35% n/a

Create Price Alert on BVS

Your price alert will notify you when the stock price is above 9.83.

Add to Watchlist